No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom.
about
HIV-1 drug resistance and resistance testing.HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan Africa.Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial.HIV-1 Subtype C, Tenofovir, and the Relationship With Treatment Failure and Drug ResistanceAn association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs.
P2860
No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
No Evidence That HIV-1 Subtype ...... t Study in the United Kingdom.
@en
No Evidence That HIV-1 Subtype ...... t Study in the United Kingdom.
@nl
type
label
No Evidence That HIV-1 Subtype ...... t Study in the United Kingdom.
@en
No Evidence That HIV-1 Subtype ...... t Study in the United Kingdom.
@nl
prefLabel
No Evidence That HIV-1 Subtype ...... t Study in the United Kingdom.
@en
No Evidence That HIV-1 Subtype ...... t Study in the United Kingdom.
@nl
P2093
P2860
P50
P356
P1476
No Evidence That HIV-1 Subtype ...... t Study in the United Kingdom.
@en
P2093
Clare Booth
David T Dunn
Duncan Churchill
Ellen White
Erasmus Smit
UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study
P2860
P304
P356
10.1093/INFDIS/JIW213
P407
P577
2016-05-24T00:00:00Z